(Q36671683)

15 August 2017

1 reference

title

Global control of sexually transmitted infections (English)

1 reference

sexually transmitted infection

15 August 2017

0 references

0 references

3

Yaw Adu-Sarkodie

1 reference

15 August 2017

1

Nicola Low

0 references

Mazeda Hossain

object named as

Mazeda Hossain

series ordinal

5

0 references

Sarah Hawkes

object named as

Sarah Hawkes

series ordinal

6

0 references

Nathalie Broutet

series ordinal

2

object named as

Nathalie Broutet

1 reference

15 August 2017

4

Pelham Barton

1 reference

PubMed ID

17141708

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

16

1 reference

inferred from page(s)

published in

The Lancet

1 reference

15 August 2017

368

1 reference

15 August 2017

9551

1 reference

15 August 2017

2001-2016

1 reference

Advances in control of sexually transmitted diseases in developing countries

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Advancement of global health: key messages from the Disease Control Priorities Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Forgotten but not gone: the continuing scourge of congenital syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Syndromic approach for treatment of STIs: time for a change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Disproportionate impact of sexually transmitted diseases on women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Sexual networks: the integration of social and genetic data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Phase specific strategies for the prevention, control, and elimination of sexually transmitted infections: case study in Lambeth, Southwark, and Lewisham, London, UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Overview: individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Structural factors in HIV prevention: concepts, examples, and implications for research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

International perspectives on individual and community approaches to the prevention of sexually transmitted disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Sexual behaviour in context: a global perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Human immunodeficiency virus infection and other sexually transmitted diseases in developing countries: public health importance and priorities for resource allocation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Once-daily valacyclovir to reduce the risk of transmission of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

How effective is syndromic management of STDs?: A review of current studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Condom use and the risk of genital human papillomavirus infection in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

HIV and male circumcision--a systematic review with assessment of the quality of studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Why do women complain of vaginal discharge? A population survey of infectious and pyschosocial risk factors in a South Asian community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Efficacy of patient-delivered partner medication in the treatment of sexual partners in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Partner notification for the control of sexually transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Improved pregnancy outcome following successful treatment of chlamydial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

An intervention study to reduce adverse pregnancy outcomes as a result of syphilis in Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Declining syphilis prevalence in pregnant women in Nairobi since 1995: another success story in the STD field?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Effect of a syphilis control programme on pregnancy outcome in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Syphilis control during pregnancy: effectiveness and sustainability of a decentralized program

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Decreased congenital syphilis incidence in Haiti's rural Artibonite region following decentralized prenatal screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

An introduction to mathematical models in sexually transmitted disease epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Comparative model-based analysis of screening programs for Chlamydia trachomatis infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The value of mass screening for chlamydia control in high prevalence communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The impact of a comprehensive chlamydia prevention program in Wisconsin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Programmes to reduce pelvic inflammatory disease--the Swedish experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Rolling out HPV vaccines worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Missing men's messages: does the reproductive health approach respond to men's sexual health needs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Transferring policies for treating sexually transmitted infections: what's wrong with global guidelines?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969482-8

7 January 2021

10.1016/S0140-6736(06)69482-8

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17141708